Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Terminated 4 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Myeloma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Burkitt Lymphoma 6 Leukemia, Biphenotypic, Acute 5 Recurrence 3 Smoldering Multiple Myeloma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, T-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Immunoglobulin Light-chain Amyloidosis 2 Hodgkin Disease 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Renal Insufficiency 1 Proteostasis Deficiencies 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Meningioma 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Lymphodepleting Chemotherapy 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Hematologic Neoplasms 1 Down Syndrome 1 Cytokine Release Syndrome 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Blood Specimen Collection 38 pembrolizumab 36 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 18 Exercise 17 Carboplatin 16 Nivolumab 15 atezolizumab 14 Cisplatin 14 Drug Therapy 13 Paclitaxel 12 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 12 Trastuzumab 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Pemetrexed 9 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Calcium Dobesilate × Clear all

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡